These include gender, smokeless tobacco usage, underlying liver diseases, anemia, leukopenia, pancytopenia, elevated ALT levels, and TCP, which are evaluated in conjunction with compensatory status and ultrasonography-identified liver fibrosis. This evidence concerns the gene GPT and Hepatic fibrosis.